Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Global Medical REIT (GMRE-PA) over the last 14 years, with Q3 2025 value amounting to $17.8 million.

  • Global Medical REIT's Accumulated Expenses rose 3339.33% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year increase of 3339.33%. This contributed to the annual value of $16.5 million for FY2024, which is 2884.75% up from last year.
  • As of Q3 2025, Global Medical REIT's Accumulated Expenses stood at $17.8 million, which was up 3339.33% from $19.0 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Accumulated Expenses registered a high of $19.0 million during Q2 2025, and its lowest value of $7.2 million during Q1 2021.
  • Its 5-year average for Accumulated Expenses is $12.8 million, with a median of $12.8 million in 2023.
  • Per our database at Business Quant, Global Medical REIT's Accumulated Expenses plummeted by 2261.11% in 2024 and then skyrocketed by 5888.65% in 2025.
  • Global Medical REIT's Accumulated Expenses (Quarter) stood at $10.3 million in 2021, then soared by 33.59% to $13.8 million in 2022, then decreased by 7.51% to $12.8 million in 2023, then rose by 28.85% to $16.5 million in 2024, then grew by 8.14% to $17.8 million in 2025.
  • Its last three reported values are $17.8 million in Q3 2025, $19.0 million for Q2 2025, and $14.5 million during Q1 2025.